Metabolomics-related Biomarkers Detection Service

The human metabolome contains all metabolites. Metabolomics-related biomarkers are closely related to human metabolic pathways and various diseases, and have broad development prospects in the field of disease research. As a leader in the field of biomarkers detection, Creative BioMart Biomarker has established a one-stop biomarkers detection service platform to provide various related research outsourcing services. Our expert team has conducted in-depth research on metabolomics technology, and can use our first-class metabolomics analysis technology platform to provide customers with high-quality metabolomics-related biomarkers detection services to achieve efficient analysis of multiple metabolites.


Similar to the human genome, the human metabolome is a collection of all metabolites present in the human body. Metabolomics is the study of all small molecules or metabolites involved in metabolism in cells, tissues or organs. With the improvement of science and technology, metabolomics technology has been developed rapidly, and metabolomics has also been extensively studied in the field of biomarkers. The human metabolome is closely related to the human genome, transcriptome and proteome, reflecting their downstream expression, so the analysis of metabolites can reflect the phenotype of the organism at a specific time. At the same time, changes in metabolite levels can be used as indicators of physiological or pathological changes in the body, providing useful information for disease pathology research, disease diagnosis and prognosis. The cure rate is very low when many diseases progress to the advanced stage, so early diagnosis of the disease is very important for the choice of disease treatment measures, the relief of the patient's symptoms and the improvement of the cure rate. Metabolomics technology has the advantages of high sensitivity, high precision and high throughput, and has shown great application prospects in the early diagnosis of diseases and the discovery of novel biomarkers. Therefore, although metabolomics is an emerging research object in the field of biomarkers, it has great potential for development and may provide new hope for the early diagnosis of various diseases.

Metabolomics-related Biomarkers Detection Service


Metabolomics-related biomarkers detection service is suitable for diagnosis, monitoring and prognosis research of various diseases, including cancers, obesity disease, neuropsychiatric disorders, cardiovascular diseases, etc.

Our Services for Metabolomics-related Biomarkers Detection (including but not limited to the following):

  • Cancer Associated Metabolites Detection Service
  • Major Metabolites Measurement Service
  • Cellular Respiration & Glycolysis Associated Metabolites Detection Service
  • Metabolic Pathways & Drug Effects

Our Advantages

  • Multiple detection technology platforms (GC-MS, NMR, LC-MS, etc.)
  • Ensure high specificity and sensitivity multiple biomarkers detection service
  • Applicable to a large number of disease-related biomarkers
  • Short turn-around time of detection service
  • Competitive price in the market of biomarkers detection services
  • Experienced technical team

Workflow of Multiple Biomarker Detection at Creative BioMart Biomarker

Metabolomics-related Biomarkers Detection Service

Creative BioMart Biomarker has been committed to providing customers with high-quality metabolomics-related biomarkers detection service. Customers can discuss with our expert team according to specific research needs or research objects. We will work out the appropriate experimental program as soon as possible. Creative BioMart Biomarker has an experienced technical team and strictly control every process in the multiple biomarker detection to ensure the accuracy and repeatability of each test result. If you have any questions about our services, please feel free to contact us, Creative BioMart Biomarker is here to offer you professional and thoughtful service.


  1. Zhang, A. H.; et al. Metabolomics for biomarker discovery: moving to the clinic. Biomed Research International. 2015, 2015: 354671.


Contact Us


Enter your email here to subscribe